Inhibition of KIT Tyrosine Kinase Activity: Two Decades After the First Approval-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of KIT Tyrosine Kinase Activity: Two Decades After the First Approval

Published:2021-05-20 Issue:15 Volume:39 Page:1674-1686
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Klug Lillian R.¹²³,Corless Christopher L.¹⁴,Heinrich Michael C.¹²³^ORCID

Affiliation:

1. Oregon Health & Science University, Knight Cancer Institute, Portland, OR

2. Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR

3. VA Portland Health Care System, Portland, OR

4. Department of Pathology, Oregon Health & Science University, Portland, OR

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.20.03245

Reference145 articles.

1. Inhibition of KIT Tyrosine Kinase Activity: A Novel Molecular Approach to the Treatment of KIT-Positive Malignancies

2. Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

3. Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome

4. Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Levels of circulating tumor DNA correlate with tumor volume in gastro‐intestinal stromal tumors: an exploratory long‐term follow‐up study;Molecular Oncology;2024-05-24

2. Triazoles in Medicinal Chemistry: Physicochemical Properties, Bioisosterism, and Application;Journal of Medicinal Chemistry;2024-05-03

3. If it’s a target, it’s a pan-cancer target: Tissue is not the issue;Cancer Treatment Reviews;2024-04

4. Individualized Dosing Patterns in the Treatment of Older Patients with Gastrointestinal Stromal Tumors: Results of a Registry-Based Observational National Cohort Study Including 871 Patients;Drugs & Aging;2023-12-20

5. c-Kit Receptors as a Therapeutic Target in Cancer: Current Insights;OncoTargets and Therapy;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3